Innate immunity against hepatitis C virus
- PMID: 27366996
- DOI: 10.1016/j.coi.2016.06.009
Innate immunity against hepatitis C virus
Abstract
Hepatitis C virus (HCV) infection tends persistent and causes chronic liver diseases, including inflammation, cirrhosis and hepatocellular carcinoma. Innate immune responses triggered by HCV infection, particularly the production of interferons and pro-inflammatory cytokines, shape the early host antiviral defense, and orchestrate subsequent HCV-specific adaptive immunity. Host has evolved multifaceted means to sense HCV infection to induce innate immune responses, whereas HCV has also developed elaborate strategies to evade immune attack. Recent studies in the field have provided many new insights into the interplay of HCV and innate immunity. In this review, we summarized these recent advances, focusing on pathogen recognition by innate sensors, newly discovered anti-HCV innate effectors and new viral strategies to evade innate immunity.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Similar articles
-
Emerging roles of interferon-stimulated genes in the innate immune response to hepatitis C virus infection.Cell Mol Immunol. 2016 Jan;13(1):11-35. doi: 10.1038/cmi.2014.127. Epub 2014 Dec 29. Cell Mol Immunol. 2016. PMID: 25544499 Free PMC article. Review.
-
Innate immune responses in hepatitis C virus infection.Semin Immunopathol. 2013 Jan;35(1):53-72. doi: 10.1007/s00281-012-0332-x. Epub 2012 Aug 7. Semin Immunopathol. 2013. PMID: 22868377 Free PMC article. Review.
-
Organ system view of the hepatic innate immunity in HCV infection.J Med Virol. 2016 Dec;88(12):2025-2037. doi: 10.1002/jmv.24569. Epub 2016 May 13. J Med Virol. 2016. PMID: 27153233 Free PMC article. Review.
-
Viral hepatitis, inflammation, and cancer: A lesson for autoimmunity.J Autoimmun. 2018 Dec;95:58-68. doi: 10.1016/j.jaut.2018.10.021. Epub 2018 Oct 26. J Autoimmun. 2018. PMID: 30509387 Review.
-
Innate detection of hepatitis B and C virus and viral inhibition of the response.Cell Microbiol. 2015 Sep;17(9):1295-303. doi: 10.1111/cmi.12489. Epub 2015 Aug 18. Cell Microbiol. 2015. PMID: 26243406 Review.
Cited by
-
Hepatitis C Virus Vaccine: Challenges and Prospects.Vaccines (Basel). 2020 Feb 17;8(1):90. doi: 10.3390/vaccines8010090. Vaccines (Basel). 2020. PMID: 32079254 Free PMC article. Review.
-
Impaired long-term anti-HBs responses in choronic hepatitis C patients: Results from a five-year follow-up study with healthy control.Hum Vaccin Immunother. 2023 Dec 31;19(1):2168432. doi: 10.1080/21645515.2023.2168432. Epub 2023 Feb 6. Hum Vaccin Immunother. 2023. PMID: 36747308 Free PMC article.
-
Neuralized E3 Ubiquitin Protein Ligase 3 Is an Inducible Antiviral Effector That Inhibits Hepatitis C Virus Assembly by Targeting Viral E1 Glycoprotein.J Virol. 2018 Oct 12;92(21):e01123-18. doi: 10.1128/JVI.01123-18. Print 2018 Nov 1. J Virol. 2018. PMID: 30111563 Free PMC article.
-
Transcription Factor MafB Suppresses Type I Interferon Production by CD14+ Monocytes in Patients With Chronic Hepatitis C.Front Microbiol. 2019 Aug 7;10:1814. doi: 10.3389/fmicb.2019.01814. eCollection 2019. Front Microbiol. 2019. PMID: 31447817 Free PMC article.
-
miR-155 regulates pro- and anti-inflammatory cytokine expression in human monocytes during chronic hepatitis C virus infection.Ann Transl Med. 2021 Nov;9(21):1618. doi: 10.21037/atm-21-2620. Ann Transl Med. 2021. PMID: 34926662 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical